Working as a Medical Sales Representative

AstraZeneca is one of the world’s most exciting bio-pharmaceutical companies. From scientists to sales, lab techs to legal we’re on a mission to turn ideas into life-changing medicines that improve patients’ lives and benefit society. We’re constantly moving forward as a company – agile and purposeful in our work. We are building a new kind of organisation, one that can improve the lives of 200 million patients and be a $50 billion company in 2025. This ambition drives us to continue to transform to be a bio-pharmaceutical company that pioneers new methods and adapts and evolves to pursue discoveries like no one else.

At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Channel Guidance: If you believe that you have experienced any medical side effects or reactions from a Novartis product you should consult your physician, pharmacist or other healthcare professional immediately. Alternatively you can also report these to us directly using the information shared on the following link: https://www.novartis.com/our-company/contact-us

The Menarini Group is the leading Italian pharmaceutical company in the world, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike. One of the Menarini Group's strong points is its collaboration with international partners: the goal is to create synergies that give rise to cutting-edge solutions, pharmaceutical products, and services in the health sector. At Menarini, quality is the basis of a shared Group strategy. All company structures are involved at different levels in the drug manufacturing process: an efficient system that has created a unique work standard for ensuring quality in every phase, from research to production, from distribution to providing scientific information. All for achieving a common goal: excellence.

LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. At LEO Pharma we understand that people power our success. Our global team – consisting of around 5,000 people in 61 countries worldwide – is our greatest asset. This is why we continually seek to attract passionate, dedicated and solution-orientated people – and ensure that our people develop their talent. Our future depends on people who can drive our activities, penetrate new territories, realise potential in existing markets and build an even stronger pipeline. Together, we can embrace change and grasp strategic business opportunities. The result: life-enhancing products that bring real value to patients.

Zuellig Pharma has been successfully serving the Asian healthcare market since 1922. During this time our network has expanded to cover the needs of 13 countries in the region. Our reputation for best in class global conduct and service excellence has remained our foundation, supporting us and our clients throughout the years. As an integral part in the development and enhancement of healthcare in Asia for almost a century, we support the business requirements of our clients, accepting both compliance and financial risk on their behalf – a service which is unique to our company and in this region. Our comprehensive set of healthcare solutions covers clinical reach, commercial, distribution, community pharmacies, as well as payor and patient solutions. Our focus has always been to support the rapid and sustained growth of our clients. We expand access to new channels and connect healthcare stakeholders, helping our clients realize their full potential in Asia.

Hyphens is Singapore’s leading specialty pharmaceutical and consumer healthcare group, leveraging on our diverse footprint in ASEAN countries. With our Group’s history dating back to 1998, we have a direct presence in five ASEAN countries – Singapore (HQ), Indonesia, Malaysia, the Philippines and Vietnam, and supplemented by a marketing and distribution network covering 10 other markets – Bangladesh, Brunei, Cambodia, China, HK S.A.R., Macau S.A.R., Myanmar, Oman, South Korea and Sri Lanka. Comprising four main business entities – Hyphens Pharma, Pan-Malayan Pharmaceuticals, Ocean Health and Novem, our core business is in three segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital